Monday, March 30, 2015

Teva buying Auspex for $3.2 billion

NEW YORK (AP) — Teva Pharmaceutical is buying Auspex Pharmaceuticals for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments. Sponcer page

No comments:

Post a Comment